Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 1.19-0.11-4.0759.1419.44

What is the latest Core EBITDA Growth ratio of VENUS REMEDIES ?

The latest Core EBITDA Growth ratio of VENUS REMEDIES is 1.19 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20241.19
Mar2023-0.11
Mar2022-4.07
Mar202159.14
Mar202019.44

How is Core EBITDA Growth of VENUS REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2024 1.19
Positive
Mar2023 -0.11
Negative
Mar2022 -4.07
Negative
Mar2021 59.14
204.22
Mar2020 19.44 -

Other Financial Ratios of VENUS REMEDIES


Compare Core EBITDA Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹410.9 Cr 5.3% -10.7% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,478.0 Cr -1.3% -4.8% 45% Stock Analytics
DIVIS LABORATORIES ₹163,822.0 Cr 0.5% 6.4% 58.2% Stock Analytics
CIPLA ₹123,920.0 Cr 2.1% 3.8% 24.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,322.0 Cr -0.6% -5.7% 5.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,217.3 Cr 0.1% -3.6% 48.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

5.3%

-10.7%

-19.6%

SENSEX

0.9%

-0.3%

20.9%


You may also like the below Video Courses